Literature DB >> 17325908

Durable remission after the administration of rituximab for EBV-negative, diffuse large B-cell lymphoma following autologous peripheral blood stem cell transplantation for angioimmunoblastic T-cell lymphoma.

Akihito Shinohara, Takashi Asai, Koji Izutsu, Yasunori Ota, Kengo Takeuchi, Akira Hangaishi, Yoshinobu Kanda, Shigeru Chiba, Toru Motokura, Mineo Kurokawa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17325908     DOI： 10.1080/10428190601059761

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  2 in total

Review 1.  Development of angioimmunoblastic T-cell lymphoma after treatment of diffuse large B-cell lymphoma: a case report and review of literature.

Authors:  Yaya Wang; Bailu Xie; Yu Chen; Zhenqian Huang; Huo Tan
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

2.  Case Report: Immune Microenvironment and Mutation Features in a Patient With Epstein-Barr Virus Positive Large B-Cell Lymphoma Secondary to Angioimmunoblastic T-Cell Lymphoma.

Authors:  Fen Zhang; Wenyu Li; Qian Cui; Yu Chen; Yanhui Liu
Journal:  Front Genet       Date:  2022-07-22       Impact factor: 4.772
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.